Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roche Holding (RHHVF)
:RHHVF
RHHVF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$233.12 - $340.88
Previous CloseN/A
Volume301.00
Average Volume (3M)4.96K
Market Cap
$265.17B
Enterprise Value$228.34B
Total Cash (Recent Filing)9.11B
Total Debt (Recent Filing)16.99B
Price to Earnings (P/E)27.5
Beta0.29
Next Earnings
Jul 24, 2025EPS Estimate
11.83Next Dividend Ex-Date
Mar 27, 2025Dividend Yield3.31%
Share Statistics
EPS (TTM)11.74
Shares Outstanding702,562,700
10 Day Avg. Volume1,294
30 Day Avg. Volume4,957
Standard Deviation0.06
R-Squared0.18
Alpha-0.00481
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$327.49Price Target Upside13.44% Upside
Rating ConsensusHold
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Clinical ReadoutsRoche will deliver a substantial number of clinical readouts which can decide a turnaround to the story.
Sales PotentialThree potential assets, each forecasted to generate over $5bn in sales, have been highlighted, with Giredestrant for 1L breast cancer showing the highest conviction.
Bears Say
Competition And SafetyData have not shown a clear benefit vs competition and safety, in particular, does not seem to provide any advantage.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
9.88% Mutual Funds
0.04% Other Institutional Investors
80.38% Public Companies and Individual Investors
RHHVF FAQ
What was Roche Holding’s price range in the past 12 months?
Roche Holding lowest stock price was $233.12 and its highest was $340.88 in the past 12 months.
What is Roche Holding’s market cap?
Roche Holding’s market cap is $265.17B.
When is Roche Holding’s upcoming earnings report date?
Roche Holding’s upcoming earnings report date is Jul 24, 2025 which is in 152 days.
How were Roche Holding’s earnings last quarter?
Roche Holding released its earnings results on Jan 30, 2025. The company reported $9.483 earnings per share for the quarter, beating the consensus estimate of $8.985 by $0.498.
Is Roche Holding overvalued?
According to Wall Street analysts Roche Holding’s price is currently Undervalued.
Does Roche Holding pay dividends?
Roche Holding pays a Annually dividend of $10.786 which represents an annual dividend yield of 3.31%. See more information on Roche Holding dividends here
What is Roche Holding’s EPS estimate?
Roche Holding’s EPS estimate is 11.83.
How many shares outstanding does Roche Holding have?
Roche Holding has 702,562,700 shares outstanding.
What happened to Roche Holding’s price movement after its last earnings report?
Roche Holding reported an EPS of $9.483 in its last earnings report, beating expectations of $8.985. Following the earnings report the stock price went up 1.384%.
Which hedge fund is a major shareholder of Roche Holding?
Currently, no hedge funds are holding shares in RHHVF
---
Company Description
Roche Holding
Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
---
RHHVF Company Deck
---
RHHVF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Roche demonstrated strong financial performance in 2024 with significant growth in sales, operating profit, and cash flow. The pharmaceutical and diagnostics divisions both showed robust growth, supported by strategic acquisitions and new product launches. However, challenges such as the decline in COVID-19 sales, impairments affecting net income, and market challenges in China were notable concerns. Overall, the highlights substantially outweigh the lowlights.Read More>---
RHHVF Stock 12 Month Forecast
Average Price Target
$327.49
▲(13.44% Upside)
Technical Analysis
Best Analysts Covering RHHVF
1 Year
1 Year Success Rate
29/45 ratings generated profit
1 Year Average Return
+4.92%
reiterated a sell rating 20 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 64.44% of your transactions generating a profit, with an average return of +4.92% per trade.
---